BETHANY WALERYSIAK: Open Payments
NPI 1477092716 · JOHNSTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$220 in 11 payments from 10 companies in 2025. Trend: 2023 $258 · 2024 $234 · 2025 $220
Food & beverage: $220
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $54 |
| ABBVIE INC. | 1 | $27 |
| PFIZER INC. | 1 | $24 |
| Pulmonx Corporation | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Aimmune Therapeutics, Inc. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
| Lilly USA, LLC | 1 | $14 |
| Merck Sharp & Dohme LLC | 1 | $14 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $12 |
Products named: VRAYLAR, Ozempic, NURTEC ODT, CHARTIS CATHETER, Kerendia, ZENPEP, AIRSUPRA, JARDIANCE.
Industry payments across PA — which companies pay providers there.
